- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 3.2 First Amendment to Amended and Restated Memorandum and Articles of Association of Health Sciences
- 4.2 Warrant to Purchase Ordinary Shares of Health Sciences Acquisitions Corporation 2 Issued to Hsac 2 Holdings, LLC, Dated August 6, 2020
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm of Health Sciences Acquisitions Corporation 2
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Orchestra Biomed, Inc.
- 99.1 Consent of Eric A. Rose, M.D. to Be Named As a Director Nominee
- 99.2 Consent of Jason Aryeh to Be Named As a Director Nominee
- 99.3 Consent of Pamela Y. Connealy to Be Named As a Director Nominee
- 99.4 Consent of Geoffrey W. Smith to Be Named As a Director Nominee
- 99.5 Consent of David P. Hochman to Be Named As a Director Nominee
- 99.6 Consent of Darren R. Sherman to Be Named As a Director Nominee
- 99.7 Consent of Eric S. Fain, M.D. to Be Named As a Director Nominee
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
- 19 Dec 22 EFFECT Notice of effectiveness
- 16 Dec 22 424B3 Prospectus supplement
- 12 Dec 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
8 Aug 22 S-4 Registration of securities issued in business combination transactions
- 21 Nov 22 Registration of securities issued in business combination transactions (amended)
- 21 Oct 22 Registration of securities issued in business combination transactions (amended)
- 23 Sep 22 Registration of securities issued in business combination transactions (amended)
- 8 Aug 22 Registration of securities issued in business combination transactions
Exhibit 99.2
Consent to be Named as a Director Nominee
In connection with the filing by Health Sciences Acquisitions Corporation 2 (“HSAC2”) of the Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement, and any and all amendments and supplements thereto, as a nominee to the board of directors of HSAC2 following the consummation of the business combination, which will be renamed Orchestra BioMed Holdings, Inc. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
Date: August 8, 2022 | Sincerely, |
/s/ Jason Aryeh | |
Jason Aryeh |